Scientists working with mice have found that a gene called ZFP191 is needed for the development of the cells that produce myelin, and that a single mutation in this gene causes the animals to suffer from a condition similar to multiple sclerosis.

Harvard researchers have found that adolescent obesity appears to increase a person’s risk of developing multiple sclerosis.

According to new studies, two drugs–fingolimod and cladribine–have shown promise in becoming the first pill-form medications for relapsing remitting multiple sclerosis.

The U.S. Food and Drug Administration has approved the extended-release drug Ampyra (dalfampridine) for adults with multiple sclerosis who have trouble walking.

A well-known yoga expert and a doctor who specializes in treating multiple sclerosis have developed a new program for people who suffer from the condition.

Multiple sclerosis patient Jeff Beal and his doctors discuss a controversial theory and procedure that Beal says has greatly improved his MS symptoms.

A well-known yoga expert and a doctor who specializes in treating multiple sclerosis have developed a new program for people who suffer from the condition.

Multiple sclerosis patient Jeff Beal and his doctors discuss a controversial theory and procedure that Beal says has greatly improved his MS symptoms.

Call for adults ages 18 years to 55 years old who have relapsing-remitting multiple sclerosis to participate in a study.